nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—PPARG—Barrett's esophagus	0.634	1	CbGaD
Glipizide—CYP2C9—Omeprazole—Barrett's esophagus	0.0827	0.389	CbGbCtD
Glipizide—CYP3A4—Esomeprazole—Barrett's esophagus	0.0816	0.384	CbGbCtD
Glipizide—CYP3A4—Omeprazole—Barrett's esophagus	0.0481	0.226	CbGbCtD
Glipizide—ABCC8—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.00504	0.181	CbGpPWpGaD
Glipizide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.00489	0.175	CbGpPWpGaD
Glipizide—Foetor hepaticus—Esomeprazole—Barrett's esophagus	0.00285	0.0226	CcSEcCtD
Glipizide—Foetor hepaticus—Omeprazole—Barrett's esophagus	0.00285	0.0226	CcSEcCtD
Glipizide—Eruption—Omeprazole—Barrett's esophagus	0.00263	0.0209	CcSEcCtD
Glipizide—Eruption—Esomeprazole—Barrett's esophagus	0.00263	0.0209	CcSEcCtD
Glipizide—Liver disorder—Esomeprazole—Barrett's esophagus	0.00237	0.0188	CcSEcCtD
Glipizide—Liver disorder—Omeprazole—Barrett's esophagus	0.00237	0.0188	CcSEcCtD
Glipizide—Hepatocellular injury—Esomeprazole—Barrett's esophagus	0.00162	0.0128	CcSEcCtD
Glipizide—Hepatocellular injury—Omeprazole—Barrett's esophagus	0.00162	0.0128	CcSEcCtD
Glipizide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.0015	0.0539	CbGpPWpGaD
Glipizide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.0015	0.0539	CbGpPWpGaD
Glipizide—Urine output increased—Omeprazole—Barrett's esophagus	0.00146	0.0116	CcSEcCtD
Glipizide—Urine output increased—Esomeprazole—Barrett's esophagus	0.00146	0.0116	CcSEcCtD
Glipizide—PPARG—Differentiation of white and brown adipocyte   —BMP4—Barrett's esophagus	0.00146	0.0522	CbGpPWpGaD
Glipizide—Hypertonia—Omeprazole—Barrett's esophagus	0.00142	0.0113	CcSEcCtD
Glipizide—Hypertonia—Esomeprazole—Barrett's esophagus	0.00142	0.0113	CcSEcCtD
Glipizide—Abnormal vision—Omeprazole—Barrett's esophagus	0.00141	0.0112	CcSEcCtD
Glipizide—Abnormal vision—Esomeprazole—Barrett's esophagus	0.00141	0.0112	CcSEcCtD
Glipizide—PPARG—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00138	0.0493	CbGpPWpGaD
Glipizide—Hepatic function abnormal—Omeprazole—Barrett's esophagus	0.00134	0.0107	CcSEcCtD
Glipizide—Hepatic function abnormal—Esomeprazole—Barrett's esophagus	0.00134	0.0107	CcSEcCtD
Glipizide—Polyuria—Esomeprazole—Barrett's esophagus	0.00134	0.0106	CcSEcCtD
Glipizide—Polyuria—Omeprazole—Barrett's esophagus	0.00134	0.0106	CcSEcCtD
Glipizide—Haemolytic anaemia—Omeprazole—Barrett's esophagus	0.0013	0.0103	CcSEcCtD
Glipizide—Haemolytic anaemia—Esomeprazole—Barrett's esophagus	0.0013	0.0103	CcSEcCtD
Glipizide—Visual disturbance—Omeprazole—Barrett's esophagus	0.00124	0.00984	CcSEcCtD
Glipizide—Visual disturbance—Esomeprazole—Barrett's esophagus	0.00124	0.00984	CcSEcCtD
Glipizide—Thirst—Esomeprazole—Barrett's esophagus	0.00123	0.00979	CcSEcCtD
Glipizide—Thirst—Omeprazole—Barrett's esophagus	0.00123	0.00979	CcSEcCtD
Glipizide—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.0012	0.00955	CcSEcCtD
Glipizide—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.0012	0.00955	CcSEcCtD
Glipizide—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00118	0.00936	CcSEcCtD
Glipizide—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00118	0.00936	CcSEcCtD
Glipizide—Diplopia—Esomeprazole—Barrett's esophagus	0.00117	0.00932	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00117	0.00932	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00117	0.00932	CcSEcCtD
Glipizide—Diplopia—Omeprazole—Barrett's esophagus	0.00117	0.00932	CcSEcCtD
Glipizide—Migraine—Esomeprazole—Barrett's esophagus	0.00115	0.00917	CcSEcCtD
Glipizide—Migraine—Omeprazole—Barrett's esophagus	0.00115	0.00917	CcSEcCtD
Glipizide—PPARG—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00109	0.0389	CbGpPWpGaD
Glipizide—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00107	0.00851	CcSEcCtD
Glipizide—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00107	0.00851	CcSEcCtD
Glipizide—Pancytopenia—Omeprazole—Barrett's esophagus	0.000963	0.00765	CcSEcCtD
Glipizide—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000963	0.00765	CcSEcCtD
Glipizide—Dysuria—Esomeprazole—Barrett's esophagus	0.000948	0.00753	CcSEcCtD
Glipizide—Dysuria—Omeprazole—Barrett's esophagus	0.000948	0.00753	CcSEcCtD
Glipizide—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000925	0.00735	CcSEcCtD
Glipizide—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000925	0.00735	CcSEcCtD
Glipizide—Jaundice—Omeprazole—Barrett's esophagus	0.000881	0.007	CcSEcCtD
Glipizide—Jaundice—Esomeprazole—Barrett's esophagus	0.000881	0.007	CcSEcCtD
Glipizide—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000879	0.00698	CcSEcCtD
Glipizide—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000879	0.00698	CcSEcCtD
Glipizide—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000855	0.00679	CcSEcCtD
Glipizide—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000855	0.00679	CcSEcCtD
Glipizide—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.000844	0.0067	CcSEcCtD
Glipizide—Agranulocytosis—Omeprazole—Barrett's esophagus	0.000844	0.0067	CcSEcCtD
Glipizide—Rhinitis—Omeprazole—Barrett's esophagus	0.000814	0.00646	CcSEcCtD
Glipizide—Rhinitis—Esomeprazole—Barrett's esophagus	0.000814	0.00646	CcSEcCtD
Glipizide—Hepatitis—Omeprazole—Barrett's esophagus	0.000812	0.00645	CcSEcCtD
Glipizide—Hepatitis—Esomeprazole—Barrett's esophagus	0.000812	0.00645	CcSEcCtD
Glipizide—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000808	0.00642	CcSEcCtD
Glipizide—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000808	0.00642	CcSEcCtD
Glipizide—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000805	0.0064	CcSEcCtD
Glipizide—Pharyngitis—Omeprazole—Barrett's esophagus	0.000805	0.0064	CcSEcCtD
Glipizide—Visual impairment—Esomeprazole—Barrett's esophagus	0.000782	0.00621	CcSEcCtD
Glipizide—Visual impairment—Omeprazole—Barrett's esophagus	0.000782	0.00621	CcSEcCtD
Glipizide—Eye disorder—Esomeprazole—Barrett's esophagus	0.000758	0.00603	CcSEcCtD
Glipizide—Eye disorder—Omeprazole—Barrett's esophagus	0.000758	0.00603	CcSEcCtD
Glipizide—Flushing—Esomeprazole—Barrett's esophagus	0.000753	0.00598	CcSEcCtD
Glipizide—Flushing—Omeprazole—Barrett's esophagus	0.000753	0.00598	CcSEcCtD
Glipizide—Chills—Omeprazole—Barrett's esophagus	0.000728	0.00579	CcSEcCtD
Glipizide—Chills—Esomeprazole—Barrett's esophagus	0.000728	0.00579	CcSEcCtD
Glipizide—Flatulence—Omeprazole—Barrett's esophagus	0.000696	0.00553	CcSEcCtD
Glipizide—Flatulence—Esomeprazole—Barrett's esophagus	0.000696	0.00553	CcSEcCtD
Glipizide—Tension—Esomeprazole—Barrett's esophagus	0.000693	0.00551	CcSEcCtD
Glipizide—Tension—Omeprazole—Barrett's esophagus	0.000693	0.00551	CcSEcCtD
Glipizide—Nervousness—Omeprazole—Barrett's esophagus	0.000686	0.00545	CcSEcCtD
Glipizide—Nervousness—Esomeprazole—Barrett's esophagus	0.000686	0.00545	CcSEcCtD
Glipizide—Muscle spasms—Omeprazole—Barrett's esophagus	0.000679	0.0054	CcSEcCtD
Glipizide—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000679	0.0054	CcSEcCtD
Glipizide—Vision blurred—Esomeprazole—Barrett's esophagus	0.000666	0.00529	CcSEcCtD
Glipizide—Vision blurred—Omeprazole—Barrett's esophagus	0.000666	0.00529	CcSEcCtD
Glipizide—Tremor—Esomeprazole—Barrett's esophagus	0.000662	0.00526	CcSEcCtD
Glipizide—Tremor—Omeprazole—Barrett's esophagus	0.000662	0.00526	CcSEcCtD
Glipizide—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000656	0.00521	CcSEcCtD
Glipizide—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000656	0.00521	CcSEcCtD
Glipizide—Malaise—Esomeprazole—Barrett's esophagus	0.000637	0.00506	CcSEcCtD
Glipizide—Malaise—Omeprazole—Barrett's esophagus	0.000637	0.00506	CcSEcCtD
Glipizide—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000636	0.0228	CbGpPWpGaD
Glipizide—Vertigo—Esomeprazole—Barrett's esophagus	0.000635	0.00504	CcSEcCtD
Glipizide—Vertigo—Omeprazole—Barrett's esophagus	0.000635	0.00504	CcSEcCtD
Glipizide—Leukopenia—Esomeprazole—Barrett's esophagus	0.000632	0.00502	CcSEcCtD
Glipizide—Leukopenia—Omeprazole—Barrett's esophagus	0.000632	0.00502	CcSEcCtD
Glipizide—Hypertension—Omeprazole—Barrett's esophagus	0.00061	0.00485	CcSEcCtD
Glipizide—Hypertension—Esomeprazole—Barrett's esophagus	0.00061	0.00485	CcSEcCtD
Glipizide—Myalgia—Omeprazole—Barrett's esophagus	0.000601	0.00478	CcSEcCtD
Glipizide—Arthralgia—Esomeprazole—Barrett's esophagus	0.000601	0.00478	CcSEcCtD
Glipizide—Myalgia—Esomeprazole—Barrett's esophagus	0.000601	0.00478	CcSEcCtD
Glipizide—Arthralgia—Omeprazole—Barrett's esophagus	0.000601	0.00478	CcSEcCtD
Glipizide—Anxiety—Omeprazole—Barrett's esophagus	0.000599	0.00476	CcSEcCtD
Glipizide—Anxiety—Esomeprazole—Barrett's esophagus	0.000599	0.00476	CcSEcCtD
Glipizide—Discomfort—Omeprazole—Barrett's esophagus	0.000594	0.00472	CcSEcCtD
Glipizide—Discomfort—Esomeprazole—Barrett's esophagus	0.000594	0.00472	CcSEcCtD
Glipizide—Confusional state—Omeprazole—Barrett's esophagus	0.000581	0.00462	CcSEcCtD
Glipizide—Confusional state—Esomeprazole—Barrett's esophagus	0.000581	0.00462	CcSEcCtD
Glipizide—Shock—Omeprazole—Barrett's esophagus	0.000567	0.00451	CcSEcCtD
Glipizide—Shock—Esomeprazole—Barrett's esophagus	0.000567	0.00451	CcSEcCtD
Glipizide—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000565	0.00449	CcSEcCtD
Glipizide—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000565	0.00449	CcSEcCtD
Glipizide—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000557	0.00443	CcSEcCtD
Glipizide—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000557	0.00443	CcSEcCtD
Glipizide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000554	0.0198	CbGpPWpGaD
Glipizide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000554	0.0198	CbGpPWpGaD
Glipizide—Anorexia—Esomeprazole—Barrett's esophagus	0.00055	0.00437	CcSEcCtD
Glipizide—Anorexia—Omeprazole—Barrett's esophagus	0.00055	0.00437	CcSEcCtD
Glipizide—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000537	0.0192	CbGpPWpGaD
Glipizide—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000525	0.00417	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000525	0.00417	CcSEcCtD
Glipizide—PPARG—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.000524	0.0188	CbGpPWpGaD
Glipizide—Insomnia—Esomeprazole—Barrett's esophagus	0.000522	0.00414	CcSEcCtD
Glipizide—Insomnia—Omeprazole—Barrett's esophagus	0.000522	0.00414	CcSEcCtD
Glipizide—Paraesthesia—Omeprazole—Barrett's esophagus	0.000518	0.00411	CcSEcCtD
Glipizide—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000518	0.00411	CcSEcCtD
Glipizide—PPARG—Adipogenesis—CYP26A1—Barrett's esophagus	0.000514	0.0184	CbGpPWpGaD
Glipizide—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000514	0.00408	CcSEcCtD
Glipizide—Dyspnoea—Omeprazole—Barrett's esophagus	0.000514	0.00408	CcSEcCtD
Glipizide—Somnolence—Esomeprazole—Barrett's esophagus	0.000513	0.00407	CcSEcCtD
Glipizide—Somnolence—Omeprazole—Barrett's esophagus	0.000513	0.00407	CcSEcCtD
Glipizide—Dyspepsia—Omeprazole—Barrett's esophagus	0.000508	0.00403	CcSEcCtD
Glipizide—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000508	0.00403	CcSEcCtD
Glipizide—Decreased appetite—Omeprazole—Barrett's esophagus	0.000501	0.00398	CcSEcCtD
Glipizide—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000501	0.00398	CcSEcCtD
Glipizide—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000498	0.00396	CcSEcCtD
Glipizide—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000498	0.00396	CcSEcCtD
Glipizide—Pain—Omeprazole—Barrett's esophagus	0.000493	0.00392	CcSEcCtD
Glipizide—Constipation—Omeprazole—Barrett's esophagus	0.000493	0.00392	CcSEcCtD
Glipizide—Pain—Esomeprazole—Barrett's esophagus	0.000493	0.00392	CcSEcCtD
Glipizide—Constipation—Esomeprazole—Barrett's esophagus	0.000493	0.00392	CcSEcCtD
Glipizide—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000475	0.00378	CcSEcCtD
Glipizide—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000475	0.00378	CcSEcCtD
Glipizide—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000471	0.00375	CcSEcCtD
Glipizide—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000471	0.00375	CcSEcCtD
Glipizide—Urticaria—Omeprazole—Barrett's esophagus	0.000458	0.00364	CcSEcCtD
Glipizide—Urticaria—Esomeprazole—Barrett's esophagus	0.000458	0.00364	CcSEcCtD
Glipizide—Abdominal pain—Omeprazole—Barrett's esophagus	0.000456	0.00362	CcSEcCtD
Glipizide—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000456	0.00362	CcSEcCtD
Glipizide—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000425	0.00338	CcSEcCtD
Glipizide—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000425	0.00338	CcSEcCtD
Glipizide—Asthenia—Omeprazole—Barrett's esophagus	0.000414	0.00329	CcSEcCtD
Glipizide—Asthenia—Esomeprazole—Barrett's esophagus	0.000414	0.00329	CcSEcCtD
Glipizide—Pruritus—Esomeprazole—Barrett's esophagus	0.000408	0.00324	CcSEcCtD
Glipizide—Pruritus—Omeprazole—Barrett's esophagus	0.000408	0.00324	CcSEcCtD
Glipizide—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000395	0.00313	CcSEcCtD
Glipizide—Diarrhoea—Omeprazole—Barrett's esophagus	0.000395	0.00313	CcSEcCtD
Glipizide—PPARG—Adipogenesis—BMP4—Barrett's esophagus	0.00039	0.014	CbGpPWpGaD
Glipizide—Dizziness—Esomeprazole—Barrett's esophagus	0.000381	0.00303	CcSEcCtD
Glipizide—Dizziness—Omeprazole—Barrett's esophagus	0.000381	0.00303	CcSEcCtD
Glipizide—Vomiting—Omeprazole—Barrett's esophagus	0.000367	0.00291	CcSEcCtD
Glipizide—Vomiting—Esomeprazole—Barrett's esophagus	0.000367	0.00291	CcSEcCtD
Glipizide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000365	0.0131	CbGpPWpGaD
Glipizide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000365	0.0131	CbGpPWpGaD
Glipizide—PPARG—Wnt Signaling Pathway Netpath—APC—Barrett's esophagus	0.000365	0.0131	CbGpPWpGaD
Glipizide—Rash—Esomeprazole—Barrett's esophagus	0.000364	0.00289	CcSEcCtD
Glipizide—Rash—Omeprazole—Barrett's esophagus	0.000364	0.00289	CcSEcCtD
Glipizide—Dermatitis—Esomeprazole—Barrett's esophagus	0.000363	0.00289	CcSEcCtD
Glipizide—Dermatitis—Omeprazole—Barrett's esophagus	0.000363	0.00289	CcSEcCtD
Glipizide—Headache—Esomeprazole—Barrett's esophagus	0.000361	0.00287	CcSEcCtD
Glipizide—Headache—Omeprazole—Barrett's esophagus	0.000361	0.00287	CcSEcCtD
Glipizide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000352	0.0126	CbGpPWpGaD
Glipizide—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000347	0.0124	CbGpPWpGaD
Glipizide—Nausea—Omeprazole—Barrett's esophagus	0.000342	0.00272	CcSEcCtD
Glipizide—Nausea—Esomeprazole—Barrett's esophagus	0.000342	0.00272	CcSEcCtD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—Barrett's esophagus	0.000286	0.0102	CbGpPWpGaD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000285	0.0102	CbGpPWpGaD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Barrett's esophagus	0.000277	0.00993	CbGpPWpGaD
Glipizide—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000253	0.00907	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000246	0.00882	CbGpPWpGaD
Glipizide—PPARG—Regulation of retinoblastoma protein—CDKN2A—Barrett's esophagus	0.000245	0.00877	CbGpPWpGaD
Glipizide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000232	0.0083	CbGpPWpGaD
Glipizide—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000229	0.00819	CbGpPWpGaD
Glipizide—PPARG—Signaling events mediated by HDAC Class I—RELA—Barrett's esophagus	0.000225	0.00805	CbGpPWpGaD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—RELA—Barrett's esophagus	0.000208	0.00746	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000208	0.00746	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000188	0.00673	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000188	0.00673	CbGpPWpGaD
Glipizide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000182	0.00653	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000151	0.00542	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000151	0.00541	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000149	0.00535	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGES—Barrett's esophagus	0.000129	0.00464	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGES—Barrett's esophagus	0.000126	0.0045	CbGpPWpGaD
Glipizide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00012	0.0043	CbGpPWpGaD
Glipizide—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000105	0.00377	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	9.99e-05	0.00358	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	9.85e-05	0.00353	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP26A1—Barrett's esophagus	9.81e-05	0.00351	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP26A1—Barrett's esophagus	9.51e-05	0.00341	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGES—Barrett's esophagus	9.28e-05	0.00332	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NR1I2—Barrett's esophagus	9.04e-05	0.00324	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.67e-05	0.00275	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—SLC9A1—Barrett's esophagus	7.07e-05	0.00253	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP26A1—Barrett's esophagus	7.03e-05	0.00252	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—SLC9A1—Barrett's esophagus	6.86e-05	0.00246	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—TP53—Barrett's esophagus	5.59e-05	0.002	CbGpPWpGaD
Glipizide—PPARG—Metabolism—SLC9A1—Barrett's esophagus	5.07e-05	0.00181	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—RELA—Barrett's esophagus	4.71e-05	0.00169	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	4.09e-05	0.00146	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGES—Barrett's esophagus	3.42e-05	0.00122	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PPARG—Barrett's esophagus	3.23e-05	0.00116	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PPARG—Barrett's esophagus	3.13e-05	0.00112	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.59e-05	0.000927	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS2—Barrett's esophagus	2.54e-05	0.000909	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS2—Barrett's esophagus	2.46e-05	0.000882	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.25e-05	0.000807	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.91e-05	0.000685	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.87e-05	0.000668	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS2—Barrett's esophagus	1.82e-05	0.000652	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.71e-05	0.000611	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.5e-05	0.000539	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.23e-05	0.000441	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARG—Barrett's esophagus	8.52e-06	0.000305	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	6.7e-06	0.00024	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARG—Barrett's esophagus	5.62e-06	0.000201	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	4.42e-06	0.000158	CbGpPWpGaD
